TEM Insider Trading

Insider Ownership Percentage: 27.60%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $352,456,255.54

Tempus AI Insider Trading History Chart

This chart shows the insider buying and selling history at Tempus AI by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$200M$0$200MTotal Insider BuyingTotal Insider Selling

Tempus AI Share Price & Price History

Current Price: $53.73
Price Change: Price Decrease of -0.037 (-0.07%)
As of 04/29/2025 12:44 PM ET

This chart shows the closing price history over time for TEM up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
JunJulAugSepOctNovDecJanFebMarApr$53.77Closing price on 04/28/25:

SEC Filings (Institutional Ownership Changes) for Tempus AI (NASDAQ:TEM)

24.22% of Tempus AI stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TEM by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$76Mbought$25MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$500M$0$500MTotal InflowsTotal Outflows
Tempus AI logo
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Read More on Tempus AI

Today's Range

Now: $53.73
Low: $52.68
High: $56.90

50 Day Range

MA: $49.28
Low: $37.23
High: $76.72

52 Week Range

Now: $53.73
Low: $22.89
High: $91.45

Volume

5,778,565 shs

Average Volume

5,675,066 shs

Market Capitalization

$9.25 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Tempus AI?

Tempus AI's top insider investors include:
  1. Bradley A Keywell (Major Shareholder)
  2. Eric P Lefkofsky (CEO)
  3. Ryan Fukushima (COO)
  4. Andrew Polovin (EVP)
  5. James William Rogers (CFO)
  6. Erik Phelps (EVP)
  7. Ryan M Bartolucci (CAO)
  8. Nadja West (Director)
  9. Jennifer A Doudna (Director)
  10. David R Epstein (Director)
  11. Wayne AI Frederick (Director)
Learn More about top insider investors at Tempus AI.

Who are the major institutional investors of Tempus AI?

Tempus AI's top institutional shareholders include:
  1. Sumitomo Mitsui Trust Group Inc. — 2.47%
  2. Renaissance Capital LLC — 0.07%
  3. Exchange Traded Concepts LLC — 0.05%
  4. Teacher Retirement System of Texas — 0.05%
  5. Westwind Capital — 0.04%
  6. Green Alpha Advisors LLC — 0.03%
Learn More about top institutional investors of Tempus AI stock.

Which institutional investors are selling Tempus AI stock?

During the previous quarter, TEM stock was sold by these institutional investors:
  1. Teacher Retirement System of Texas
  2. IMC Chicago LLC
  3. Janney Capital Management LLC
  4. Farther Finance Advisors LLC
In the last year, company insiders that have sold Tempus AI company stock include:
  1. Bradley A Keywell (Major Shareholder)
  2. Eric P Lefkofsky (CEO)
  3. Ryan Fukushima (COO)
  4. Andrew Polovin (EVP)
  5. James William Rogers (CFO)
  6. Erik Phelps (EVP)
  7. Ryan M Bartolucci (CAO)
  8. Nadja West (Director)
  9. Jennifer A Doudna (Director)
  10. David R Epstein (Director)
  11. Wayne AI Frederick (Director)
Learn More investors selling Tempus AI stock.

Which institutional investors are buying Tempus AI stock?

During the previous quarter, TEM stock was acquired by institutional investors including:
  1. Sumitomo Mitsui Trust Group Inc.
  2. Renaissance Capital LLC
  3. Westwind Capital
  4. Clarity Capital Partners LLC
  5. RFG Advisory LLC
  6. Cambridge Investment Research Advisors Inc.
  7. Green Alpha Advisors LLC
  8. Aspiriant LLC